Avelios Medical, a provider of next-generation hospital information systems (HIS), has secured €30 million ($31M) in Series A funding led by Sequoia Capital, alongside existing investors Revent and HTGF. This investment accelerates Avelios’ mission to become the leading operating system for intelligent patient care.

Founded in 2020 by Christian Albrecht, Nicolas Jakob, and Dr. Sebastian Krammer, Avelios is redefining hospital workflows with its AI-driven HIS 2.0, optimizing patient data management from admission to billing. With SAP exiting the HIS market by 2030, hundreds of hospitals across Germany and Europe face a critical IT transition, creating a unique opportunity for Avelios to enhance patient care and operational efficiency. The system reduces administrative burdens, addresses preventable medication errors—responsible for 65,000 deaths annually in Germany—and integrates structured data for AI-powered diagnostics.

Avelios’ comprehensive HIS covers treatment documentation, billing, and patient management, all while ensuring top-tier data security within European data centers. Its modular, scalable architecture allows hospitals to customize implementation. Already adopted by major healthcare providers like Sana, Ludwig-Maximilians-University Munich, and Hannover Medical School, Avelios is a key player in digital transformation.

Sequoia Capital’s Anas Biad praised Avelios for its ambitious vision, emphasizing the platform’s depth, scalability, and strong hospital feedback. With this funding, Avelios is set to revolutionize hospital information systems, positioning itself as a leader in the evolving healthcare IT landscape.